The Motley Fool

What market crash? Here are 2 FTSE 100 shares I believe may continue to be successful in July

What a volatile six months it has been in broader markets. Following the bull market of January and February, the coronavirus that initially affected China became a global pandemic. As countries went into lockdowns, panic hit the markets. Yet after the market lows in March, many FTSE 100 shares had stellar run-ups in price.

Not every FTSE 100 stock has recovered fully, but there are several shares that are up considerably in 2020. It has now become a stock-pickers market. Those investors who concentrate on the new post-Covid-19 economy are likely to continue doing well in the second half of the year. Therefore, I’d like to discuss two FTSE 100 shares that are up in 2020. I believe they still deserve to be on your radar.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

Highest market capitalisation in the FTSE 100

My first choice for today is pharma giant AstraZeneca (LSE: AZN), whose shares are up 13% year-to-date (YTD). The group is now the UK’s biggest company by market capitalisation. It’s worth over £111bn. Before the market crash, oil major Royal Dutch Shell was heading the list. But the downturn has pushed the share price down by over 43% so far in the year. And the company is now number eight on the list. What a change of fortunes.

AZN shares have been buoyed in part by pharmaceutical companies’ relative safety amid the health and economic effects of the pandemic. Investors are also ready to pay a premium for its portfolio of drugs. That may be why the stock price has almost doubled in the past five years. In July 2016, it was around 4,280p. Now it is hovering at 8,460p.

The group concentrates on several major disease areas, including cancer, cardiovascular, diabetes, gastrointestinal, infection, inflammation and respiratory. A wide range of pharma companies are currently racing to develop a vaccine against Covid-19 and AZN is one of the forerunners. In mid-June the pharma giant announced that (assuming a vaccine works) it would supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit.”

As a result, the share price has been reacting extremely well. If AZN shares had been your only portfolio holding, you might not have thought that there has been a market crash in 2020. Shareholders also enjoy a current dividend yield of 2.65%. 

Consumer rules

The second stock I want to highlight is consumer goods giant Reckitt Benckiser (LSE: RB). This year, RB shares are up over 21%.

I expect the volatility in the markets to continue in the coming weeks. Another market crash could also happen. Therefore I’d make defensive stocks part of any long-term portfolio. Analysts regard consumer staples companies as defensive. People continue to buy household items, cleaning products, and other essentials such as personal hygiene products, even when their salaries are shrinking. And the potential second wave of the viral outbreak means everyone must pay more attention to basic hygiene than before.

On 30 April, the group also released Q1 results and reported record quarterly sales growth. The robust results were led by increased demand for many of its hygiene products, such as Dettol and Lysol, and health products like MucinexNurofen, and VMS.

Reckitt Benckiser’s current dividend yield stands at 2.6%. The shares are expected to go ex-dividend in August. The FTSE 100 group feels to me like a must-have if you want a consumer-defensive company in your portfolio.

Before I forget...

A top income share that boasts a reliably defensive business model… plus a current forecast dividend yield of 4.2% to boot!

With global markets in turmoil as the coronavirus pandemic tightens its grip, turning to shares to generate income isn’t as simple as it used to be…

As the realities of ‘life under lockdown’ begin to bite, many of the stock market’s ‘go-to’ high-yielding companies have either taken an axe to their dividend pay-outs… or worse, opted to suspended them altogether – for the near-term at least.

With so many blue-chip and mid-cap companies scrambling to hoard cash right now, where are we income investors to turn for decent yields?

Fortunately, The Motley Fool is here to help…

Our analyst has unearthed what he believes could be a very attractive option for income- seeking investors – a company that, in his view, boasts a ‘reliably defensive’ business model, combined with a current forecast dividend yield of 4.2% to boot!*

But here’s the really exciting part…

This business even has form in riding out this kind of situation, too… having previously increased sales and profits back in 2008 and 2009 when the world was gripped in the deepest economic crisis since the Great Depression.

*Please be aware that dividends are variable and not guaranteed.

Click here to claim your copy of this special report now — and we’ll tell you the name of this Top Income Share… free of charge!

tezcang has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.